Analytical Data
-
基因名
CD84
- Application
-
别名
SLAM family member 5. Cell surface antigen MAX.3. Hly9-beta. Leukocyte differentiation antigen CD84. Signaling lymphocytic activation molecule 5. CD84
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9UIB8
-
表达区间
1-328aa
-
氨基酸序列
MAQHHLWILLLCLQTWPEAAGKDSEIFTVNGILGESVTFPVNIQEPRQVKIIAWTSKTSVAYVTPGDSETAPVVTVTHRNYYERIHALGPNYNLVISDLRMEDAGDYKADINTQADPYTTTKRYNLQIYRRLGKPKITQSLMASVNSTCNVTLTCSVEKEEKNVTYNWSPLGEEGNVLQIFQTPEDQELTYTCTAQNPVSNNSDSISARQLCADIAMGFRTHHTGLLSVLAMFFLLVLILSSVFLFRLFKRRQDAASKKTIYTYIMASRNTQPAESRIYDEILQSKVLPSKEEPVNTVYSEVQFADKMGKASTQDSKPPGTSSYEIVI
-
分子量
63.3 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CD84 is a member of the signaling lymphocytic activation molecule (SLAM) family, which plays a crucial role in immune response regulation. It is primarily expressed on the surface of immune cells, such as T cells, B cells, and dendritic cells. Research into CD84 has gained significance due to its potential involvement in immune-related diseases, including autoimmune disorders and cancer. The understanding of CD84's functions and its interactions with other immune receptors has led to increasing interest in developing recombinant proteins for therapeutic applications. These recombinant CD84 proteins can be used as tools in studies to elucidate the signaling pathways and mechanisms by which CD84 modulates immune responses. Additionally, they may serve as potential biomolecular agents for targeting specific immune pathways, thus offering new avenues for treatment strategies in diseases characterized by dysregulated immune activation. Overall, the investigation of CD84 recombinant proteins represents a promising frontier in immunology, holding the potential to enhance our understanding of immune regulation and contribute to novel therapeutic interventions.
